People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Pharmaceuticals, Other, Biotechnology, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omthera Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $92.7M | $598.5M | 2011 |
| Jocasta Neuroscience, Inc. | — | Other | Series B | $31.6M | $180.7M | 2024 |
| SonoThera, Inc. | — | Biotechnology | Series B | $30.4M | $550.2M | 2022 |
| American Distributors Holding Co., LLC | — | Manufacturing | Series A | $11.0M | $49.9M | 2018 |
Michael Davidson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Davidson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Asish Xavier | 1 | 18 |
| Brian Halak | 1 | 10 |
| David Mott | 1 | 9 |
| Steve Brown | 1 | 5 |
| Michael Bruno | 1 | 4 |
| David Beck | 1 | 4 |
| Lori Hu | 1 | 3 |
| Stephen Hanna | 1 | 3 |
| Kevin Rose | 1 | 3 |
| Michael Steinback | 1 | 3 |
| Graziano Seghezzi | 1 | 3 |
| Timothy Fulham | 1 | 3 |
| Gerald Wisler | 1 | 2 |
| Bernardus Machielse | 1 | 2 |
| Tom Willis | 1 | 2 |
| Kenneth Greenberg | 1 | 2 |
| Douglas Carr | 1 | 2 |
| Christian Schade | 1 | 2 |
| George Horner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.